RNA binding proteins (RBPs) are the primary gene regulators in kinetoplastids as transcriptional control is nearly absent, making Leishmania an exceptional model for investigating methylation of non-histone substrates. Arginine methylation is an evolutionarily conserved protein modification catalyzed by Protein aRginine MethylTransferases (PRMTs). The chromatin modifier PRMT7 is the only Type III PRMT found in higher eukaryotes and a restricted number of unicellular eukaryotes.
INTRODUCTION
Protein arginine methyltransferases (PRMTs) are widely distributed across eukaryotes in 11 different classes of enzymes (PRMT1-11). They catalyze arginine methylation in multiple cellular processes including histone modification, transcription control, RNA processing, protein localization and cell signaling (1) (2) (3) (4) . Histones and RNA-binding proteins (RBPs) have been characterized as PRMT substrates in different organisms (1) .
PRMTs are classified as Type I, II or III according to the targeted nitrogen and number of methyl groups transferred ( Figure 1B ). PRMT7 is a unique enzyme as it is the sole PRMT known to catalyze only monomethyl arginine (MMA; Type III PRMT), which may indicate a regulatory step that primes substrates prior to dimethylation (5) (6) (7) . PRMT7 has been well described in mammalian cells as a histone methyltransferase which modulates chromatin to repress gene promoters.
Remarkably, the only unicellular eukaryotes known to carry a PRMT7 homolog are choanoflagellates and trypanosomatids, including Leishmania, where gene expression control is primarily post-transcriptional (8) . The heightened regulatory role of RBPs in Leishmania can lend clear functional insight not obscured by complex networks of transcriptional regulation (9) .
Leishmania spp. parasites are the causative agent of the leishmaniases, infectious diseases that contribute the ninth largest global disease burden, with 1 million new cases diagnosed annually (10) . We have previously shown that Leishmania major PRMT7 expression is stage-regulated during development, regulates host pathology and localizes to the cytoplasm unlike the nuclearspecific mammalian PRMT7 (11) . Remarkably, the Leishmania PRMT7-directed regulatory pathway epigenetically controls parasite gene expression, and resultant pathology outcomes 4 cellular differentiation events and 4 months after PRMT7 protein expression.
The impact of PRMT7 on the overall MMA-modified proteome is still unknown. To date, histones are the only mammalian PRMT7 targets validated in vivo (6, 12) . In contrast, L. major PRMT7 displays distinct localization, low sequence similarity and is nonessential. Combined with the negligible transcriptional control in Leishmania spp., all evidence suggests a divergent function between human and Leishmania PRMT7 enzyme (11) . A recent large-scale study compared the distribution of arginine residues across eukaryotes and found that unicellular organisms that carry a PRMT7 homolog (including Monosiga brevicolis and Leishmania infantum) have a higher ratio of predicted methylarginine/unmodified arginine than others (Plasmodium falciparum and Dictyostelium discoideum) (4) . Indeed both Leishmania major and Trypanosoma brucei PRMT7s are distinct enough from mammalian orthologs that the regulatory pathways they drive may present anti-parasitic drug targets or an opportunity to repurpose existing drugs (5, 11, 12) . We previously demonstrated that PRMT7 levels are inversely proportional to L. major parasite virulence, functionally linking this enzymatic pathway to leishmaniasis pathogenesis (11) .
Here, we present the first comprehensive investigation of the molecular impact of modulating PRMT7 levels and the first quantified identification of a Leishmania arginine monomethyl proteome. Using methyl-SILAC proteomics, we identified 247 arginine monomethylated proteins, including 62 RNA-binding proteins (RBPs); 17 of which are hypomethylated upon PRMT7 knockout.
RBPs are the primary genetic regulators in Leishmania species as genes are constitutively transcribed (9) . We further validate PRMT7 methylation targets both in vitro and in vivo and reveal arginine methylation as an important post-translational regulator of RBP function with differential impact upon individual trans-regulators. PRMT7-dependent monomethylation promotes cytoplasmic RBP16 protein stability as well as controls the highly selective mRNA binding capacity of Alba3; stabilizing δ-amastin surface antigen mRNA levels but not impacting association or stability of nmt transcript target. The near-absence of transcriptional control in Leishmania amplifies the regulatory role of trans-regulators and renders it an excellent system to investigate the impact of PTMs on RBP function (8) . This study introduces Leishmania PRMTs as epigenetic regulators of downstream parasite virulence via modified RBP protein expression, selective RNA binding capacity and subsequent mRNA metabolism.
MATERIAL AND METHODS

Leishmania major cultures and transfection
Leishmania major promastigotes strain CC1 (MHOM/IR/83/LT252) were cultured at 26°C in M199 medium supplemented with 40 mM HEPES, 10% FBS, 100 U penicillin/mL, 100 μg/mL, 100 μM adenine, 0.0005% Hemin. In the phlebotomine vector, L. major parasites differentiate from the proliferative non-infective procyclic promastigotes to the non-dividing human-infective metacyclic promastigotes, a metacyclogenesis process that is mimicked in culture (13) . Procyclics and metacyclics are enriched in axenic culture, respectively, at log and stationary growth phases.
Inside mammalian phagocytic cells (primarily macrophages) metacyclic promastigotes differentiate into non-motile amastigotes.
PRMT7 null parasites (Δprmt7) were previously generated (11) . Plasmid and PCR oligos used in this study are shown in Supplementary Figure S2 and Table S3 , respectively. The coding sequence (CDS) and 500bp 5' flanking region (FLR) of RNA-binding proteins Torus (LmjF.36.0740), DDX3 (LmjF.32.0400), RBP16 (LmjF.28.0825) and Alba3 (LmjF.34.2580) were PCR amplified. The cloning strategy involved using four different SfiI enzyme sites to allow a single-step four-way ligation: SfiA (GGCCACCTAGGCC), SfiB reverse (GGCCACGCAGGCC), SfiC (GGCCGCTGGGGCC) and SfiD reverse (GGCCTGACTGGCC) (14) . PCR products were purified using NucleoSpin Gel and PCR Clean-up (Macherey-Nagel), cloned into pGEM®Teasy vector (Promega), SfiI digested and ligated into plasmid pFLAG_HA-RBP (Supplementary Figure S2A ). Positive clones were confirmed by diagnostic restriction and sequencing, PmeI-PacI digested overnight and purified DNA was transfected into L. major WT and ∆prmt7 using Amaxa Nucleofector IIb (Lonza). Transfectants were selected on 1% agar M199 plates with 10 µg/mL G418 and PCR-validated using 5'FLR and 3'FLR primers
(Supplementary Figures S2B and C).
Alba3 hypomethylated mutants were generated by replacing arginine residues (RG/RGG motifs) in the C-terminus to either tryptophan (WGG) or lysine (R192K or KGG) and inserting each construct into pFLAG_HA-Alba3. For the latter, alba3 sequence was modified by Q5® Site-Directed Mutagenesis (New England Biolabs), according to manufacturer instructions, using oligos shown in Table S3 to either replace a single arginine detected in the MMA methyl-SILAC analysis (Alba3 R192K ) or all the eleven arginine residues in RGG motifs present in its C-terminal tail (Alba3 KGG ). The Alba3 WGG mutant sequence was obtained as a custom synthetic gene (GenScript), in which each of the eleven arginine residues were mutated. Final constructs were transfected into both WT and Δprmt7 L. major cell lines.
Parasite labeling by SILAC
Heavy methyl-SILAC has been shown to provide high confidence methyl peptide matches, and it is considered the optimal method for identifying protein methylation in large-scale proteomics (15) .
Parasites were cultured for 10 passages in SILAC-RPMI media (RPMI lacking Methionine (Dundee Cell Products), 10% 3.5 kDa-dialyzed serum, 20 mM HEPES pH 7.4, 100 μM adenine, 20 mM Lglutamine, 100 U/mL penicillin, 100 µg/mL streptomycin, 1 µM biopterin, 0.0005% hemin) supplemented with either L-methionine or L-methionine-methyl-13 CD 3 (Sigma-Aldrich), for 10 passages corresponding to approximately 100 parasite divisions. L-methionine is converted into Sadenosylmethionine (SAM), the main biological methyl donor for transmethylation reactions, which allows direct labelling of methylated substrates (3). Next, J774.2 macrophages kept in SILAC-RPMI media for 4 passages were infected with late-stationary phase promastigotes at a 10:1 ratio to obtain recently differentiated promastigotes, as prolonged axenic promastigote culturing can alter virulence-related features (16) . Three hours post-infection, plates were washed in incomplete RPMI and kept for 48 h under the same conditions. Amastigotes were purified and differentiated into procyclic promastigotes in SILAC-RPMI at 26 o C and cultured for 3 passages.
Parasite protein extraction and enrichment of monomethylated arginine peptides
Logarithmic procyclic promastigotes (10 9 parasites) were pelleted at 2,000 g for 10 min, washed in PBS and lysed (20 mM HEPES pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate) via three rounds of sonication at 15 W for 15 s at room temperature (RT) to avoid urea precipitation with 1 min intervals on ice. Lysates were cleared at 20,000 g, 20 min, 15 o C and supernatants were collected.
Sample preparation and enrichment of monomethyl arginine peptides were conducted using PTMScan[mme-RG] kit (Cell Signaling Technology) according to manufacturer's protocols with the following modifications: proteins were reduced in 4.5 μM DTT at 55 o C for 30 min, cooled on ice and alkylated in 2 mg/mL iodoacetamide at RT for 15 min. Lysates were diluted 3-fold in 20 mM HEPES pH 8.0 and digested overnight in 10 μg/mL trypsin-TPCK (Sigma-Aldrich) and 10 μM HCl, at RT under agitation. Digestion was confirmed by SDS-PAGE and Coomassie Blue R staining. Digests were acidified with trifluoroacetic acid (17) to a final concentration of 0.1% and a pH strip was used to confirm a pH < 3. Precipitate was formed at RT for 15 min. Peptides were purified using a Sep-Pak C 18 column (Waters) connected to a 10 cc reservoir, pre-wet in 5 mL 100% acetonitrile and washed sequentially in 1, 3 and 6 mL 0.1% TFA. Acidified peptide solution was cleared at 1,800 g for 15min at RT and cleared supernatant was loaded onto the C 18 column using a 10 cc plunger.
The column was washed sequentially in 1, 5 and 6 mL 0.1% TFA and then in 2 mL 5% acetonitrile, 0.1% TFA. Peptides were collected by 3 elutions in 2 mL 40% acetronitrile, 0.1% TFA and dried in a Speed-Vac concentrator for approximately 3 h.
Dry peptide pellets were dissolved in 1.4 mL Immunoaffinity Purification (IAP) buffer (CST) and pH ~7.0 was confirmed on a pH strip. All subsequent steps were performed on ice or at 4 o C. Peptide solution was cleared at 10,000 g for 5 min and supernatant was transferred to a fresh tube. Anti-MMA agarose beads from the PTMScan kit were washed 4 times at 2,000 g for 1 min, in 1 mL PBS (8 mM Na 2 HPO 4 ; 1.5 mM NaH 2 PO 4 ; 2.7 mM KCl; 137 mM NaCl; pH 7.0) and resuspended in 40 μL PBS. Peptide solution was mixed with the anti-MMA beads and incubated for 2 h under rotation.
Peptide-beads slurry was centrifuged at 2,000 g for 1 min and unbound peptides were collected and kept at -80 o C. Beads were washed twice in 1 mL IAP buffer and three times in HPLC-grade water; inverting the tube 5 times and centrifuged at 2,000 g for 1 min. MMA peptides were collected by 2 elutions in 55 μL of 0.15% TFA at RT for 10 min, mixing every 2 min, and centrifuged at 2,000 g for 1 min.
Eluted monomethyl peptides were concentrated and purified using a Ziptip (Merck-Millipore). The Ziptip was first equilibrated in 50 μL of 50% acetronitrile, 0.1% TFA and twice in 50 μL of 0.1% TFA.
IP eluent was loaded by passing through the Ziptip 10 times. Tips were washed twice in 0.1% TFA and peptides were eluted in 10 μL 40% acetonitrile, 0.1% TFA at least 10 times. Ziptip eluent was precipitated in a Speed-Vac and MMA peptides were resuspended in 10 μL of 0.1% TFA.
Mass spectrometry data acquisition and analysis
Samples were loaded onto an UltiMate 3000 RSLCnano HPLC system (Thermo) equipped with a PepMap 100 Å C 18 , 5 μm trap column (300 μm x 5 mm, Thermo) and a PepMap, 2 μm, 100 Å, C 18 EasyNano nanocapillary column (75 μm x 150 mm, Thermo). The trap wash solvent was 0.05% with 99% solvent B for 4 min. The column was returned to initial conditions and re-equilibrated for 15 min before subsequent injections.
The nanoLC system was interfaced with an Orbitrap Fusion hybrid mass spectrometer (Thermo) with an EasyNano ionisation source (Thermo). Positive ESI-MS and MS 2 spectra were acquired using Xcalibur software (version 4.0, Thermo). Instrument source settings were: ion spray voltage, 1,900 V; sweep gas, 0 Arb; ion transfer tube temperature; 275°C. MS 1 spectra were acquired in the Orbitrap with: 120,000 resolution, scan range: m/z 375-1,500; AGC target, 4e 5 ; max fill time, 100 ms. Data dependant acquisition was performed in top speed mode using a 1 s cycle, selecting the most intense precursors with charge states 2-5. Dynamic exclusion was performed for 50s post precursor selection and a minimum threshold for fragmentation was set at 3e 4 . MS 2 spectra were acquired in the linear ion trap with: scan rate, rapid; quadrupole isolation, 1.6 m/z; activation type, HCD; activation energy: 32%; AGC target, 5e 3 ; first mass, 110m/z; max fill time, 100 ms.
Acquisitions were arranged by Xcalibur to inject ions for all available parallelizable time.
Peptide Identification
Protein identification was performed using Sequest HT and Mascot. Thermo .raw files were submitted to Sequest HT database searching using Proteome Discoverer (version 2.1, Thermo).
Peak lists were extracted following .raw to .mgf format conversion using MSconvert (version Scaffold PTM (version 3.0.0, Proteome Software) was used to calculate methylation site localization probabilities for Mascot derived peptide identifications using the algorithm as described (19) . Briefly, MS 2 spectra identified as originating from methylated peptides were re-analyzed to calculate Ascore values and site localization probabilities to assess the level of confidence in each PTM positional assignment. Scaffold PTM then combined localization probabilities for all peptides containing each identified PTM site to obtain the best estimate probability that a PTM is present at that particular site. .raw files were converted to .mzML using Bioconductor (version 3.5) in R (version 3.3.1) before processing using the xcms package (20) . XICs were extracted for all theoretical light and heavy m/z pairs across retention time aligned samples within 60 s windows, and peak areas extracted using the centWave algorithm (21) . Light and heavy peak areas were normalized to relative percentages (light/heavy) and the reciprocal percentage (heavy/light) calculated for replicates originating from switched light to heavy metabolic labelling. Significance testing for quantitative differences between normalized light and heavy peak areas was performed using Student's t-test (two-tailed, heteroscedastic). Calculated p-values were multiple-test corrected using the Hochberg and Benjamini false discovery rate estimation. Accepted differences were required to have corrected p-values <0.05, be derived from XIC peak areas in >2 samples and be observed consistently in at least one replicate upon light to heavy metabolic label switching.
Relative Quantification of Methylated Peptides
Bioinformatic analyses of PRMT7 MMA RNA binding protein targets
Amino acid sequences of 18 PRMT7 targets were downloaded from TriTrypDB.org (18) and subjected to a set of bioinformatic tools to predict the type and location of constituent domains.
Initial Pfam (22) domain annotations were obtained using BLASTP (23) and RefSeq and PDB sequence databases. Predictions of secondary structure and intrinsic disorder were performed using PSIPRED (24) and DISOPRED (25) , respectively. Additional structural predictions were conducted using Phyre2 in standard mode (26) . The results of these analyses were combined to inform manual predictions of likely domain boundaries and to annotate domain type and function.
Extended regions of predicted secondary structure and low disorder that lacked a clear functional annotation were assigned as domains of unknown function (DUF).
In vitro methylation assay by PRMT7
Recombinant proteins were expressed in Escherichia coli BL21(DE3)pLys using pET28a+ (Novagen) and purified using Ni-Sepharose affinity medium (GE Healthcare) as previously described (11) . Reactions were loaded and run on 12.5% SDS-PAGE and gels were dried on Whatman paper in a vacuum (Gel Dryer 583, Bio-Rad) for 2 h at 80 o C on a gradient drying cycle. The dried gel was exposed to Hyperfilm (GE Healthcare) for 3-14 days at -70 o C. Gels were also stained with Coomassie R for loading control. Gels and films were scanned on an ImageScanner III (GE Healthcare) for posterior analysis using GIMP (GNU Image Manipulation Program).
Immunoblotting
Promastigotes at log or stationary growth phase (10 7 cells per lane) were sedimented at 2,000 g for 10 min, washed once in PBS under the same conditions, lysed in 2X SDS sample buffer and boiled 5 min before loading on 12.5% SDS-PAGE gels. Proteins were transferred to PVDF membranes at 20 V for 1 h using a Novex Semi-Dry blotter (Thermo). Blots were blocked in 5% 
RNA immunoprecipitation and qRT-PCR
HA-Alba3 was immunoprecipitated from in vivo UV-crosslinked log promastigotes with anti-HA magnetic beads (Thermo) as described (9, 28) . Crosslinking was performed with UVC using the LT40 "Minitron" system (UV03 Ltd; (Granneman, 2010 #817)) for 120 s at 1.6mJ/cm 2 , which is less stressful to parasites and damaging to mRNA (9) . Total RNA was extracted from WT and Δprmt7 input samples using Direct-zol RNA Miniprep (Zymo Research). cDNA was synthesized from 2 µg of total RNA or 100-400 ng of RIP RNA using the SuperScript IV Reverse Transcriptase (Invitrogen). Supplementary Table S3 .
Protein and mRNA decay
For protein stability evaluation, promastigotes at day 2 (log phase; non human-infective promastigote) or day 6 (stationary phase; human-infective promastigote) post-inoculum were incubated in 200 μg/mL cycloheximide at 26 o C up to 24 h. Cells were harvested at specific timepoints and resuspended in 2X Sample buffer (as above). A volume equivalent to 10 7 cells/lane was loaded on 12.5% SDS-PAGE and assessed by immunoblot as described above. Membranes were stained post-transfer in Ponceau for loading controls. Densitometry analysis was performed using ImageJ software (29) For transcript stability analysis, log phase promastigotes were incubated up to 4 h in 2.5 μg/mL sinefungin (Cayman Chemical) and 5 μg/mL actinomycin D (Sigma) to inhibit trans-splicing and de novo transcription (30) . Sinefungin was added 15 min before actinomycin D. Cells (2x10 7 ) were harvested at specific time points and lysed in Trizol reagent (Invitrogen). Total RNA was extracted using Direct-zol RNA Miniprep (Zymo Research). RNA levels were quantified by qRT-PCR as explained above and normalized to 18S rRNA.
RESULTS
RNA-binding proteins are the primary targets of arginine monomethylation in L. major
To evaluate the impact of PRMT7 loss upon the arginine monomethyl proteome of Leishmania major, wild-type (WT) and Δprmt7 parasites were labeled with either L-methionine (31) or Lmethionine-methyl-13 CD 3 (heavy) and submitted for methyl-SILAC proteomic analysis ( Figure 1A ).
Expression of PRMT7 was similar between light and heavy methyl-labeled parasites ( Figure 1C ) and no significant growth difference was observed between WT and ∆prmt7 cells, light or heavy ( Figure 1D ). Heavy methionine incorporation of >95% was confirmed by LC-MS ( Figure 1E ), which is sufficient and essential for SILAC analyses (32) . Supplementary   Table S1 ). In total, these proteins are represented by 387 unique MMA peptides identified. Mass spectrometry analysis of unfractionated peptides (input) did not show significant differential expression of total methylated proteins between wild-type and Δprmt7 samples. Supplementary Table S2 ), we found 24 differentially methylated in Δprmt7 cells, of which 17 are hypomethylated and represent putative substrates of PRMT7 activity ( Supplementary Table S2 ).
Analysis of the peptide sequences surrounding the methylated arginines using WebLogo 3 (33) demonstrate differential residue selection between the hypomethylated arginines versus total MMA proteome in Δprmt7 cells. The global MMA data do not present a significant motif consensus, with 10-20% probability for glycines to surround the methylarginine ( Figure 2C ).
However, there is a strong selection evident for RG/RGG (or GR/GGR) motifs in the hypomethylated PRMT7 substrate peptides ( Figure 2D ), revealing a candidate target motif for the PRMT7 enzyme. Of interest, MMA sites in isolated hypomethylated RBPs reside outside conserved Interpro/Pfam domains (Figure 3 ), suggesting RBP-RNA interactions might not be directly obstructed.
Validating RBP substrates of PRMT7 methylation
From the list of proteins hypomethylated in Δprmt7, we selected Alba3 (Alba20; (Ferreira, 2014 #628) (34, 35) ) and RBP16 for further investigation (Figure 2A ). Alba3 is a RPP25-like protein (ribonuclease P subunit p25-like) involved in the stabilization of the δ-amastin virulence factor mRNA upregulated in amastigotes (35) . RBP16 is a Y-box binding protein (YBX2-like) important for trypanosomatid mitochondrial mRNA editing and stabilization (36) . Our previous investigation identified these two RBPs as candidate targets of PRMT7 methylation (11) . To determine whether these RBPs are directly targeted by PRMT7 methylation, purified recombinant 6xHis-tagged PRMT7 (His-PRMT7) and putative substrates His-Alba3 and His-RBP16 were tested for activity in vitro. We first confirmed His-PRMT7 activity is detectable in vitro using a commercially available human Histone H4, a canonical target of mammalian PRMTs ( Figure 4A ). In the absence of substrate, it appeared His-PRMT7 automethylates ( Figure 4A ), however we found this to be artifactual and disappeared when replaced with an alternative His sequence (data not shown).
Next, we examined His-PRMT7 methylation of recombinant His-RBP16 and His-Alba3, as well as a mutant protein devoid of the RGG-rich C-terminal tail (His-Alba3 ΔRGG , Figure 4B ). His-PRMT7 methylates His-Alba WT and His-RBP16 WT in vitro in a concentration-dependent manner but not His-Alba3 ΔRGG ( Figure 4C ). This indicates that recombinant PRMT7 is sufficient to monomethylate both RBP targets directly and that PRMT7-catalyzed methylation requires the C-terminal RGG motifs of Alba3, despite 18 additional non-RGG arginine residues still present in His-Alba3 ΔRGG . As a negative control, we examined the potential for PRMT7 to modify a Leishmania protein containing 12 arginine residues but lacking a defined RGG motif, His-PGF2S (LbrM.31.2410, Figure 4B ). PGF2S is not methylated by PRMT7 in vitro ( Figure 4C ).
Building upon these observations, we generated two catalytically-inactive PRMT7 mutants to confirm conservation of the catalytic site in Leishmania and the specificity of the observed methylation signal. In other eukaryotes, key glutamate (E) residues in the double E loop of the SAM-binding domain have been replaced to generate inactive PRMT mutants (37, 38) . Analysis of the double E loop sequence of PRMTs in L. major showed conservation of residues E202 and E211 (Supplementary Figure S1 ). The first glutamate residue in this domain (E202) was mutated to either a glutamine or lysine accordingly. In contrast to His-PRMT7 WT , recombinant His-PRMT7 E202Q and His-PRMT7 E202K do not methylate His-Alba3 or His-RBP16 ( Figure 4D ) in vitro. These results confirm the catalytic domain and the double E loop are essential for PRMT7-dependent monomethylation of RBP targets in vitro.
Loss of PRMT7 impacts RBP expression and function in vivo
To investigate a possible role of MMA arginine in mRNA metabolism in Leishmania parasites, the N-termini of target RBPs were endogenously HA-tagged, leaving 3'UTRs intact as transcript stability and translational control are overwhelmingly 3'UTR-driven (39) . Wild-type and ∆prmt7 parasites were engineered to express HA-tagged Alba3, RBP16, Torus and DDX3 RBPs (Supplementary Figure S2) . Torus is a CCCH-type zinc finger protein with a conserved Torus domain that, like DDX3 (HEL67; (Padmanabhan, 2016 #780)) co-immunoprecipitates with PRMT7 (11) . Examination of candidate target HA-RBP levels in WT and ∆prmt7 promastigotes at log (proliferative) and stationary (non-proliferative) growth stages show that three RBPs are differentially expressed ( Figure 5A ). Both HA-Torus and HA-RBP16 have reduced expression in ∆prmt7 parasites, the former at both log and stationary phase, the latter only in stationary phase promastigotes. In contrast, HA-DDX3 is slightly upregulated in ∆prmt7 at stationary phase with potential degradative products evident. The detection of a smaller HA-DDX3 band of ~30 kDa at the stationary phase suggests enzymatic cleavage, a possible sign of protein instability and tightly coordinated control of expression. The observation that HA-RBP16 protein levels are reduced in Δprmt7 relative to wildtype human-infective stationary promastigote cells ( Figure 5A ) is particularly interesting as PRMT7 expression is tightly downregulated prior to this lifecycle stage (11) . The stage-specific eradication of RBP16 levels in the ∆prmt7 mutant cells was therefore examined in two different but complementary experimental contexts.
To determine whether reduced HA-RBP16 levels in Δprmt7 cells are due to expedited protein decay rates or reduced translation of rbp16 transcript, the protein stability of both RBP16 and Alba3 was assessed over a time course in translationally-inhibited WT and Δprmt7 cells ( Figure 5B and Supplementary Figures S3B, S3C ). Of note, HA-RBP16 degradation is significantly faster in the absence of PRMT7 levels than in WT cells with the half-life of HA-RBP16 reduced specifically in stationary phase Δprmt7 cells relative to WT background or log phase ( Figure 5B ). In contrast, stability of HA-Alba3 protein was unchanged between samples ( Supplementary Figures S3B, S3C ).
Densitometry analysis revealed HA-RBP16 protein half-life is >6 h in WT and 0.5 h in Δprmt7 cells
at stationary phase ( Figure 5B and Supplementary Figure S3C ). This suggests PRMT7-dependent methylation can post-translationally control select target protein degradation rates in a stagespecific manner.
To determine whether the half-life of HA-RBP16 was impacted by subcellular localization, Nterminally tagged HA-RBP16 was examined using immunofluorescence. Similar to immunoblot results, the HA-RBP16 protein signal specifically decreases in Δprmt7 promastigotes at stationary phase (Supplementary Figure S4C ). Unlike the close RBP16 orthologue in T. brucei, TbRBP16 (36, 40) N-terminally tagged HA-RBP16 localises in the cytoplasm and does not traffick to the mitochondria (Supplementary Figure S4C ). Cytoplasmic localization of HA-Alba3 was unaltered between promastigotes samples (Supplementary Figure S4C) . We therefore examined the subcellular localisation and relative stability of endogenous LmjRBP16 using anti-TbRBP16 (kind gift of L.Read) and found that while the HA-RBP16 protein is cytoplasmic, untagged endogenous LmjRBP16 is indeed mitochondrial (Supplementary Figure S4C) . We tested the subcellular localisation of C-terminally-tagged endogenous RBP16-HA and found it is also mitochondrial (data not shown). This suggests N-terminal HA tagging of LmjRBP16 is sufficient to disrupt proper mitochondrial localisation and correlates with the absence of bound cytoplasmic RNA targets (data not shown). Of note, neither the mitochondrial-localised endogenous LmjRBP16 or endogenously tagged RBP16-HA are destabilized in the stationary cell stage in the absence of PRMT7 levels. As rbp16 transcript is nuclear-derived and cytoplasmically translated, there is biological relevance to the relative stability of this potential metabolic regulator in the cytoplasm. This provides two useful mechanistic insights, firstly that PRMT7 methylation can shield a cytoplasmic RBP from protein degradation in an in vivo context and secondly that the protein degradative machinery context differs significantly between both cytoplasmic and mitochondrial cellular compartments and the distinct lifecycle stages.
PRMT7-mediated methylation modulates post-transcriptional gene control
Similarly, endogenous levels and subcellular localisation of HA-Alba3 remain unaltered by removal of PRMT7 expression ( Supplementary Figure S4D) . We generated hypomethylated Alba3 WGG heterozygous mutants with RGG methyl sites replaced by WGG in the protein C-terminus to evaluate possible effects of an increased hydrophobicity in this region. In contrast to other RBPs investigated, there were no changes in either endogenously tagged HA-Alba3 WT or HA-Alba3 WGG protein levels between transfectants at the two promastigote stages analyzed ( Figure 6A ). Therefore, we investigated the potential influence of arginine methylation on Alba3 mRNA-binding function. Immunoprecipitation of HA-Alba3 and probing with anti-MMA revealed that monomethylation is only detected in WT cells and absent in HA-Alba3 WGG mutant protein expressed in both WT and Δprmt7 cell lines ( Figure 6B) , validating the C-terminal RGG motifs are necessary for in vivo Alba3 methylation by PRMT7.
Next, we addressed the RNA-binding properties of hypomethylated Alba3 protein. Previously, LiAlba3 has been shown to bind to δ-amastin (LinJ.34.1010) and p1/s1 nuclease (LinJ.30.1520) transcripts in Leishmania infantum cells (28) . Therefore, we tested whether Alba3 RNA-binding is conserved and impacted by PRMT7-dependent methylation. Promastigotes cells were UV-crosslinked in vivo followed by anti-HA RNA co-immunoprecipitation to isolate HA-Alba3 mRNP complexes and specific transcript targets were identified via RNA MiSeq and quantified by qRT-PCR. Remarkably, endogenous HA-Alba3 showed differential RNA-binding affinity in the absence of PRMT7-dependent methylation. The in vivo interaction of Alba3 with stage-regulated mRNAs δamastin (LmjF.34.0500) and p1/s1 nuclease (LmjF.30.1510) is dependent on methylation by PRMT7 ( Figure 6C) . In contrast, Alba3 binding to the constitutively expressed nmt (Nmyristoyltransferase) and gapdh mRNA targets is not altered by PRMT7 knockout. While total δamastin expression levels are reduced in Δprmt7, p1/s1 nuclease expression is unchanged, suggesting divergent regulatory mechanisms between the two transcripts.
To further analyze Alba3 binding to δ-amastin, HA-Alba3 WT , HA-Alba3 WGG , HA-Alba3 R192K and HA-Alba3 KGG mRNPs were purified from WT and Δprmt7 samples and quantified by qRT-PCR.
Interaction between Alba3 and δ-amastin mRNA was again inhibited in Δprmt7 cells in vivo
( Figures 6C, 6D and 7C ). This interaction was disrupted in HA-Alba3 WGG and HA-Alba3 KGG ( Figures   6D and 7C) , corroborating the role of C-terminal tail methylation upon Alba3 RNA-binding capacity. As a control, nmt mRNA associated with Alba3 at similar levels in WT and Δprmt7 cells and nmt expression was unchanged ( Figures 6E and 7C, Supplementary Figure S3A ). Interestingly, mutation of a verified PRMT7 arginine target amino acid to a lysine (R192K) did not disrupt Alba3 association with δ-amastin or nmt, but was sufficient to disrupt Alba3 association with p1s1 target transcript ( Figure 7C) . Indeed, the trypsin digest of proteins prior to isolation of monomethylated peptides likely disrupted the proper identification of multiple RGG motif-containing peptides from the Alba3 C-terminus. This suggests Alba3 association with δ-amastin mRNA requires PRMT7dependent monomethylation of C-terminal RGG motifs in addition to R192.
Of interest, quantification of total δ-amastin levels revealed reduced expression in Δprmt7 cells, suggesting regulation via MMA-Alba3 binding (Supplementary Figure S3A and Figure 6E ). It has been reported that Alba3 participates in the stabilization of δ-amastin mRNAs in L. infantum (34) .
We thus investigated if PRMT7-mediated methylation could affect δ-amastin transcript stability.
Samples from cells treated with sinefungin and actinomycin, to block RNA trans-splicing and transcription, respectively, revealed that δ-amastin is only stabilized when Alba3 is monomethylated ( Figures 6E and 7C ). Either PRMT7 knockout or expression of hypomethylated Alba3 (HA-Alba3 WGG ) resulted in a significant decrease of δ-amastin mRNA half-life (from > 3.5 h in WT, to 1 h in Δprmt7). In contrast, no significant changes were observed in the stability of the constitutively expressed nmt target transcript between samples (Figures 6E and 7C) . Importantly, this indicates PRMT7-dependent MMA methylation of Alba3 impacts RNA binding in a targetspecific manner. Collectively our data demonstrate methylation by PRMT7 can regulate the relative protein stability and selective RNA affinity of distinct RBP targets.
DISCUSSION
To date, a limited number of arginine methylated proteins have been identified in Leishmania spp. (11, 41) . In this study, we report that 3% (~247) of the entire L. major predicted proteome carries at least one monomethylated arginine (42) . This number of MMA-targeted proteins is relatively large considering arginines can also be dimethylated and since other post-translational modifications (PTMs) have been detected in Leishmania spp., including ~600 phosphorylated proteins (7%) (43) . We demonstrate that PRMT7-dependent methylation strongly impacts the MMA proteome of L.major parasites thus regulating RBP expression and/or function (Figure 8 ).
Notably, PRMT7 levels regulate the expression levels of three isolated RBP targets in at least one developmental stage, suggesting that arginine methylation can affect protein turnover in Leishmania spp.
Overall, experimental evidence indicates Leishmania major PRMT7 activity impacts protein target stability and function in a context-dependent manner, distinct from that of mammalian homologs.
Despite not being an essential protein in L. major, PRMT7 levels regulate leishmaniasis disease pathology (11) . Remarkably, epigenetic control by PRMT7-dependent monomethylation of the primary gene regulators in this system, RBPs, mediates virulence of the human-infective lifecycle stage at least two differentiation events downstream of PRMT7 expression. This undermines the traditional paradigm that influential trans-regulators are temporally synchronized with the cellular processes they promote and provides another layer of depth to the complexities of Leishmania genetics.
Interestingly, 17 proteins are hypermethylated in Δprmt7 parasites (Figures 2A and 2B ). This may suggest modulation of alternative PRMT activity to functionally compensate for PRMT7 depletion.
Six of the hypermethylated proteins also contain concurrent hypomethylated distal sites;
indicative of a complex PRMT inter-regulatory system. Deletion of mammalian PRMT1, which catalyzes asymmetric dimethylarginine (ADMA), results in an increase of global MMA in mammals and T.brucei (44, 45) . Therefore, functional overlap between Leishmania PRMTs may involve a dynamic regulatory interplay as it does in T.brucei (46) . A unique example of substrate competition by PRMTs in human cells is regulation of transcription elongation factor E2F-1-mediated apoptosis by arginine methylation (47) . Here, PRMTs determine apoptotic outcomes by competing for the same substrate as SDMA methylation of E2F-1 by PRMT5 leads to apoptosis in DNA damaged cells, while ADMA methylation by PRMT1 favors proliferation. The detection of PRMT3 MMA peptides (LmjF.03.0600; Supplementary Table S1 ) further supports methyltransferase inter-regulation.
While PRMT3 is catalytically inactive in T. brucei due to the absence of key residues in the SAMbinding domain (48) , the two essential glutamate residues in the double-E loop are still present in Leishmania, suggesting a different regulatory role for LmjPRMT3. This exciting distinction suggests PRMT3 may be a functional enzyme rather than a prozyme in Leishmania.
Arginine methylation sites vary considerably according to the PRMT enzyme or the organism investigated (3, 38, 46, 49) . RG and RXR sites represent the majority of mammalian PRMT target motifs but there are exceptions (1, 38, 46) . The present methyl-SILAC analysis identified RG/RGG as the main target for PRMT7 methylation in vivo. Conserved protein domain analysis revealed that most of PRMT7-dependent methylation is not found directly within classical RNA-binding domains ( Figure 3 ). Of interest, no histone MMA peptides were identified by our screen. This could be due to the cytoplasmic localisation of LmjPRMT7, methodological limitations or a low overall abundance of MMA in Leishmania histone proteins.
Although arginine methylation has been mostly associated with changes in protein-protein interactions (50, 51) , there are previous examples of direct modulation of RNA-protein binding in mammalian cells (52) (53) (54) . PRMTs have previously been shown to regulate the RNA affinity of target RBPs in other systems (55, 56) . In T. brucei, the RNA-binding proteins DRBD18 and PRMT1 have been shown to modulate the fate of mRNAs according to methylation state, impacting both protein and mRNA binding (45, 50) . Here we dissect the effect of MMA upon RNA affinity and isolate the specific arginines of Alba3 that are monomethylated by PRMT7; resulting in the discrete maintenance or loss of specific transcript targets. In line with the previous finding that L.
infantum Alba3 stabilizes δ-amastin transcripts (34), we find that overall δ-amastin levels are significantly reduced in the ∆prmt7 mutant L. major lines, most likely due to reduced association Figure   S3A ). Notably, expression levels of Alba target transcript p1/s1 nuclease are not altered by PRMT7 levels, although arginine methylation of Alba3 is necessary for association. These results suggest Alba3 regulates mRNA fate in a highly bespoke, target-specific manner. There is a low correlation between protein expression and mRNA binding capacity of RBPs and mRNPs display contextdependent selection of components in Leishmania (9) . Further investigation of the molecular requirements and functional impact of RBP modification is therefore crucial to understanding gene regulation not only in Leishmania, but all eukaryotes.
The impact upon RNA binding potential may be indirect. The CCCH zinc finger protein ZFP3 is known to associate with ZFP1 in T.brucei and this interaction is necessary for both RNA target specificity as well as polysomal association (58) . Here, we identify ZFP3 as a target of PRMT7dependent MMA in Leishmania (Figure 2A) . It is possible a ZFP3:ZFP1 interaction could be impacted by the presence of methylarginine altering both the RBP spatial proximity and RNA target binding. In silico docking analyses suggest several residues in the Alba domain are buried inside the Alba3:Alba1 heterodimeric protein complex but the RGG motif in the C-terminal tail is exposed (35, 59) . Consistent with the absence of RGG motifs, the Alba1 protein was not detected in our methyl-SILAC analysis. It is not known whether methylation of the Alba3 RGG tail regulates the stress-induced localization of the Alba proteins (35) . Proper characterization of MMA target RBP structural dynamics is necessary to determine the impact of methylation on mRNP complex assembly.
Unusually, PRMT7-dependent methylation promotes the stability of cytoplasmic RBP16 protein beyond the temporal expression of PRMT7 protein levels. The regulation of protein turnover observed represents a novel function for PRMT7-dependent methylation (Figures 5A, 5B ). T. brucei RBP16 was the first Y-box protein to be found in mitochondria, where it associates with guide RNAs (gRNAs) and has a role in mitochondrial mRNA editing (27, 36) . The N-terminal cold-shock domain and RGG-rich C-terminus of TbRBP16 both contribute to RNA-binding capacity (60) .
Arginine residues in the T. brucei RBP16 C-terminus are targeted by PRMT1 methylation, impacting RNA editing complexes (36) . We find that RBP16 in Leishmania is also mitochondrial and this localization is not affected by the absence of PRMT7 (Supplementary Figure S4B ). However, the Nterminal tagging of endogenous RBP16 protein renders it cytoplasmic, where the RBP half-life is specifically reduced in ∆prmt7 knockout cells in a human-infective stage (Supplementary Figure   S4B ). This reduced stability suggests protein degradation can be inhibited in wild-type cells via PRMT7-dependent methylation, which is particularly interesting at a lifecycle stage in which PRMT7 is not expressed. This lends insight into the distinct microenvironments influencing protein degradation in cytoplasm versus mitochondria which can determine RBP function and stability.
Potential mechanisms include inhibition of protein ubiquitination and proteasome degradation targeting. Interdependent ubiquitination and methylation has been detected previously in other systems (61, 62) . Cytoplasmic protein turnover rate is largely regulated by the ubiquitinproteasome system and polyubiquitination is the classical marker for this pathway (63) . In mammalian innate immune response, TNF receptor-associated 6 (TRAF6) ubiquitin ligase activity is inhibited by PRMT1 methylation (62) . Activation of Toll-like receptor response leads to hypomethylated TRAF6 via demethylation by JMJD6 and downregulation of PRMT1 expression.
This triggers TRAF6 ubiquitin ligase activity and NF-kB response. In L. major, a putative JMJD6 demethylase ortholog gene may enable dynamic arginine methylation in protozoa (Tritrypdb.org).
To fully understand the function of RBP16 in these parasites we must examine other PTMs controling RBP16 function.
The Lsm domain-containing SCD6 is another protein with simultaneous identification of hypo-and hypermethylated sites in the data presented here. This RBP is involved in processing body (P-body) granule formation in T. brucei; specifically responsible for coordinating granule assembly (64) . In conclusion, we introduce Leishmania as a model organism to specifically study PRMT activity and functional impact of methylation upon non-histone targets. We explore methyl-SILAC as a productive, verified approach to investigate protozoa PRMT function and target isolation. Endogenously tagged Alba3 WT , RGG->KGG single point mutant (Alba3 R192K ) and hypomethylated mutant (Alba3 KGG ) showed no differential expression levels between WT and ∆prmt7 cells. The migration of HA-Alba3 KGG mutant protein is faster on SDS-PAGE, independent of PRMT7 levels. 
